Curaleaf
Dr. Robert Schnoll serves as Program Co-Leader at the Abramson Cancer Center of the University of Pennsylvania. He is an Associate Professor of Psychiatry and an internationally recognized expert in risk prevention and intervention, epidemiology, patient education and counseling, tobacco addiction, nicotine dependence and treatment, and national health policy and ethics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Curaleaf
42 followers
Curaleaf (CSE: CURA) is a leading vertically integrated cannabis operator in the United States. Headquartered in Wakefield, Massachusetts, Curaleaf is located in 10 states and owns and operates 26 dispensaries, 10 cultivation sites and 9 processing sites with a focus on highly populated, limited license states, including Florida, Massachusetts, New Jersey and New York.